Cp. Avila et al., RETINAL BLOOD-FLOW MEASUREMENTS IN BRANCH RETINAL VEIN OCCLUSION USING SCANNING LASER-DOPPLER FLOWMETRY, American journal of ophthalmology, 126(5), 1998, pp. 683-690
PURPOSE: To determine capillary blood flow measurements in eyes with b
ranch retinal vein occlusion using a scanning laser Doppler flowmeter.
METHODS: Retinal capillary blood flow in branch retinal vein occlusio
n areas and corresponding ipsilateral nonbranch retinal vein occlusion
areas, 11 equivalent areas of the contralateral fellow eye of 12 cons
ecutive untreated branch retinal vein occlusion patients, and 16 eyes
of 11 age-matched normal control subjects were measured with scanning
laser Doppler flowmetry. A template consisting of eight squares, each
with a field of 100 x 100 mu m (10 x 10 pixel) with space interval of
500 mu m equidistant horizontally and vertically was used to obtain bl
ood flow measurements in all subjects. Mean blood volume, flow, and ve
locity were obtained by averaging the mean values measured in each fie
ld. We avoided measurement over large retinal vessels to prevent the a
liasing artifact of blood cells from moving faster than the sampling f
requency. RESULTS: Branch retinal vein occlusion areas have significan
tly decreased microvascular blood volume (P =.0009), flow (P =.02), an
d velocity (P =.016) compared with ipsilateral nonbranch retinal vein
occlusion areas in the same eye. Branch retinal vein occlusion areas a
lso have decreased blood volume (P =.001), flow (P =.0042), and veloci
ty (P =.0044) compared with areas of contralateral fellow eyes of bran
ch retinal vein occlusion subjects. Branch retinal vein occlusion area
s have significantly decreased blood volume (P =.0012), flow (P =.008)
, and velocity (P =.02) compared with age-matched normal areas. CONCLU
SION: Average retinal blood volume, flow, and velocity in areas of bra
nch retinal vein occlusion are significantly lower than in healthy ret
inas. The ability to noninvasively measure hemodynamic changes in the
retinal capillary bed may be relevant to development of new therapies
for retinovascular disease. (Am J Ophthalmol 1998;126:683-690. (C) 199
8 by Elsevier Science Inc. All rights reserved.).